MAP3K13 Antikörper (AA 506-835) (Biotin)
-
- Target Alle MAP3K13 Antikörper anzeigen
- MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
-
Bindungsspezifität
- AA 506-835
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MAP3K13 Antikörper ist konjugiert mit Biotin
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Mitogen-activated protein kinase kinase kinase 13 protein (506-835AA)
- Isotyp
- IgG
- Top Product
- Discover our top product MAP3K13 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
- Andere Bezeichnung
- MAP3K13 (MAP3K13 Produkte)
- Synonyme
- LZK antikoerper, MEKK13 antikoerper, MLK antikoerper, C130026N12Rik antikoerper, lzk antikoerper, map3k13 antikoerper, map3k13a antikoerper, mekk13 antikoerper, map3k13-a antikoerper, map3k13-b antikoerper, map3k13b antikoerper, mitogen-activated protein kinase kinase kinase 13 antikoerper, mitogen-activated protein kinase kinase kinase 13 L homeolog antikoerper, mitogen-activated protein kinase kinase kinase 13 S homeolog antikoerper, MAP3K13 antikoerper, Map3k13 antikoerper, map3k13.L antikoerper, map3k13 antikoerper, map3k13.S antikoerper
- Hintergrund
-
Background: Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.
Aliases: EC 2.7.11.25 antibody, Leucine zipper bearing kinase antibody, Leucine zipper-bearing kinase antibody, LZK antibody, M3K13_HUMAN antibody, MAP3K13 antibody, MEKK13 antibody, MGC133196 antibody, Mitogen activated protein kinase kinase kinase 13 antibody, Mitogen-activated protein kinase kinase kinase 13 antibody, Mixed lineage kinase antibody, MLK antibody, OTTHUMP00000210397 antibody
- UniProt
- O43283
- Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2
-